2021 American Transplant Congress
Outcomes of Surgical Resection versus Liver Transplantation in Hilar Cholangiocarcinoma
*Purpose: To compare the outcomes of patients with hilar cholangiocarcinoma (hCCA) who underwent either surgical resection or liver transplantion (LT).*Methods: All hCCA patients who underwent…2021 American Transplant Congress
Incidentally Detected Malignancies in Lung Explants: Single Center Case Series
*Purpose: Thoracic malignancies are difficult to prospectively diagnose in patients with end-stage lung disease due to complex radiologic features. We present a series of lung…2021 American Transplant Congress
Cancer-Specific Mortality in Solid Organ Transplant Recipients with a Prior Cancer Diagnosis
*Purpose: A history of cancer is increasingly common among solid organ transplant candidates, and transplant-associated immunosuppression may increase recurrence risk. We assessed whether transplantation was…2021 American Transplant Congress
Review of Outcomes After Diagnosis of Malignancy in Kidney Transplant Patients: Unos Database
*Purpose: Malignancy is the third major cause of death among transplant recipients. Among the transplant recipients, Patient and kidney transplant outcomes after the diagnosis of…2021 American Transplant Congress
Prostate Cancer Mortality is Not Worse Among Kidney Transplant Recipients Compared to Dialysis Patients
*Purpose: Recent recommendations from expert panel of American Society of Transplantation (AST) state that most patients with prostate cancer (PCa) do not need to wait…2021 American Transplant Congress
Development of De-novo Malignancies After Kidney and/or Pancreas Transplantation in Diabetic Patients
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Transplantation of a kidney (KTA), pancreas (PTA), or a simultaneous pancreas-kidney (SPK) in a patient with end-stage organ failure is a lifesaving treatment. Patient…2021 American Transplant Congress
Posttransplant Malignancy in HIV+ Kidney Transplant Recipients
*Purpose: Kidney transplant recipients and people living with HIV are both at increased risk for malignancy, including cancers that are virally-mediated. Despite the recognition of…2021 American Transplant Congress
Associations of Mammalian Target of Rapamycin Inhibitors with Post-Transplant Malignancies and All-Cause Mortality: Cause-Specific Competing Risks and Composite Outcomes Analyses
1University of Florida, Gainesville, FL, 2University of Rhode Island, Kingston, RI
*Purpose: We investigated the outcomes of malignancies and mortality associated with mammalian target of rapamycin inhibitor (MTORI) regimens in adult kidney transplant (KT) recipients (KTRs).*Methods:…2021 American Transplant Congress
Long Term Survival After Liver Transplantation for Advanced, Unresectable Intrahepatic Cholangiocarcinoma
1Houston Methodist Hospital, Houston, TX, 2MD Anderson Cancer Center, Houston, TX
*Purpose: Intrahepatic cholangiocarcinoma (ICCA) has traditionally been considered a contraindication to liver transplantation (LT). We previously reported a case series of six patients with large,…2020 American Transplant Congress
Waiting List Mortality of Liver Tumors
Division of Transplantation, Massachusetts General Hospital, Boston, MA
*Purpose: Liver transplantation has been approved for hepatocellular carcinoma (HCC), hilar cholangiocarcinoma (CCA) and metastatic neuroendocrine tumors (NET), with the aim to produce similar outcomes…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 20
- Next Page »